Combination of somatostatin-analogs with dopamineor growth hormone receptor antagonist

Details for Australian Patent Application No. 2007255416 (hide)

Owner Novartis AG

Inventors Vincenzi, Beatrice; Schmid, Herbert

Agent Davies Collison Cave

Pub. Number AU-A-2007255416

PCT Pub. Number WO2007/141306

Priority 60/804,200 08.06.06 US

Filing date 6 June 2007

Wipo publication date 13 December 2007

International Classifications

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61P 5/08 (2006.01) Drugs for disorders of the endocrine system

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/141306 Priority application(s): WO2007/141306

11 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007255418-Process for preparing spray dried formulations of TMC125

2007255408-Stabilized pharmaceutical compositions comprising fesoterodine